Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
1
17%
Ph phase_3
2
33%
Ph phase_2
2
33%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(3)
Other(1)

Detailed Status

Completed3
Not yet recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)

Trials by Status

completed350%
not_yet_recruiting117%
recruiting117%
unknown117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_4

Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study

NCT07416968
not_yet_recruiting

Mirabegron in Patients With Age-Related Macular Degeneration

NCT07305298
completedphase_3

A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder

NCT05282069
completedphase_2

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134
unknownphase_2

Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP

NCT03632772
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07416968Phase 4

Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study

Recruiting
NCT07305298

Mirabegron in Patients With Age-Related Macular Degeneration

Not Yet Recruiting
NCT05282069Phase 3

A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder

Completed
NCT03566134Phase 2

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

Completed
NCT03632772Phase 2

Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP

Unknown
NCT01166438Phase 3

Anticholinergic vs. Botox Comparison Study

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6